on MEDIAN TECHNOLOGIES (EPA:ALMDT)
Median Technologies to Highlight AI Imaging at ESMO 2026
Median Technologies, a leader in AI-powered imaging services for oncology trials, will showcase its capabilities at the ESMO Congress 2026 in Madrid. From October 23 to 26, attendees can visit booth #1098 to learn about the latest advancements in central imaging and AI analysis for cancer trials.
An interactive session will focus on RANO 2.0, a new framework for neuro-oncology imaging reviews, set for October 25. Presenters include Antoine Iannessi and Anne-Sophie Auroux, both VPs at Median Technologies.
Additionally, the company will present an ePoster on the "Prevalence of Emphysema in Patients with Non-Small Cell Lung Cancer," highlighting key insights into imaging's role in lung cancer care.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MEDIAN TECHNOLOGIES news